Literature DB >> 22279111

Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

Martin Ugander1, Abiola J Oki, Li-Yueh Hsu, Peter Kellman, Andreas Greiser, Anthony H Aletras, Christopher T Sibley, Marcus Y Chen, W Patricia Bandettini, Andrew E Arai.   

Abstract

AIMS: Conventional late gadolinium enhancement (LGE) cardiac magnetic resonance can detect myocardial infarction and some forms of non-ischaemic myocardial fibrosis. However, quantitative imaging of extracellular volume fraction (ECV) may be able to detect subtle abnormalities such as diffuse fibrosis or post-infarct remodelling of remote myocardium. The aims were (1) to measure ECV in myocardial infarction and non-ischaemic myocardial fibrosis, (2) to determine whether ECV varies with age, and (3) to detect sub-clinical abnormalities in 'normal appearing' myocardium remote from regions of infarction. METHODS AND
RESULTS: Cardiac magnetic resonance ECV imaging was performed in 126 patients with T1 mapping before and after injection of gadolinium contrast. Conventional LGE images were acquired for the left ventricle. In patients with a prior myocardial infarction, the infarct region had an ECV of 51 ± 8% which did not overlap with the remote 'normal appearing' myocardium that had an ECV of 27 ± 3% (P < 0.001, n = 36). In patients with non-ischaemic cardiomyopathy, the ECV of atypical LGE was 37 ± 6%, whereas the 'normal appearing' myocardium had an ECV of 26 ± 3% (P < 0.001, n = 30). The ECV of 'normal appearing' myocardium increased with age (r = 0.28, P = 0.01, n = 60). The ECV of 'normal appearing' myocardium remote from myocardial infarctions increased as left ventricular ejection fraction decreased (r = -0.50, P = 0.02).
CONCLUSION: Extracellular volume fraction imaging can quantitatively characterize myocardial infarction, atypical diffuse fibrosis, and subtle myocardial abnormalities not clinically apparent on LGE images. Taken within the context of prior literature, these subtle ECV abnormalities are consistent with diffuse fibrosis related to age and changes remote from infarction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22279111      PMCID: PMC3350985          DOI: 10.1093/eurheartj/ehr481

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  35 in total

1.  Age related changes of the collagen network of the human heart.

Authors:  C R Gazoti Debessa; L B Mesiano Maifrino; R Rodrigues de Souza
Journal:  Mech Ageing Dev       Date:  2001-07-31       Impact factor: 5.432

2.  Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.

Authors:  C G Brilla; R C Funck; H Rupp
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

3.  An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging.

Authors:  Daniel R Messroghli; Andre Rudolph; Hassan Abdel-Aty; Ralf Wassmuth; Titus Kühne; Rainer Dietz; Jeanette Schulz-Menger
Journal:  BMC Med Imaging       Date:  2010-07-30       Impact factor: 1.930

4.  Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease.

Authors:  R Hesselstrand; A Scheja; D M Wuttge; H Arheden; M Ugander
Journal:  Scand J Rheumatol       Date:  2010-10-05       Impact factor: 3.641

5.  Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

Authors:  Andrew S Flett; Martin P Hayward; Michael T Ashworth; Michael S Hansen; Andrew M Taylor; Perry M Elliott; Christopher McGregor; James C Moon
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

6.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

7.  Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease.

Authors:  Craig S Broberg; Sumeet S Chugh; Catherine Conklin; David J Sahn; Michael Jerosch-Herold
Journal:  Circ Cardiovasc Imaging       Date:  2010-09-20       Impact factor: 7.792

8.  Correlation of myocardial interstitial collagen in the right ventricular septum with ventricular function of patients with ischemic cardiomyopathy.

Authors:  Marcelo Westerlund Montera; Cantídio Drumond; Cristina Takiya; Cláudio Tinoco Mesquita; Hans Fernando R Dohmann; Charles Mady
Journal:  Arq Bras Cardiol       Date:  2009-01       Impact factor: 2.000

9.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Authors:  Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

10.  Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus.

Authors:  Erik B Schelbert; Stephen M Testa; Christopher G Meier; William J Ceyrolles; Joshua E Levenson; Alexander J Blair; Peter Kellman; Bobby L Jones; Daniel R Ludwig; David Schwartzman; Sanjeev G Shroff; Timothy C Wong
Journal:  J Cardiovasc Magn Reson       Date:  2011-03-04       Impact factor: 5.364

View more
  219 in total

Review 1.  Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.

Authors:  Ljuba Bacharova; Martin Ugander
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

2.  MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction.

Authors:  Jing Xu; Baiyan Zhuang; Arlene Sirajuddin; Shuang Li; Jinghan Huang; Gang Yin; Lei Song; Yong Jiang; Shihua Zhao; Minjie Lu
Journal:  Radiology       Date:  2019-11-26       Impact factor: 11.105

3.  Quantitative assessment of myocardial fibrosis in an age-related rat model by ex vivo late gadolinium enhancement magnetic resonance imaging with histopathological correlation.

Authors:  Pascale Beliveau; Farida Cheriet; Stasia A Anderson; Joni L Taylor; Andrew E Arai; Li-Yueh Hsu
Journal:  Comput Biol Med       Date:  2015-08-08       Impact factor: 4.589

Review 4.  Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging.

Authors:  Puskar Pattanayak; David A Bleumke
Journal:  Radiol Clin North Am       Date:  2014-12-18       Impact factor: 2.303

Review 5.  Cardiac MRI for the evaluation of oncologic cardiotoxicity.

Authors:  Adrián I Löffler; Michael Salerno
Journal:  J Nucl Cardiol       Date:  2018-05-07       Impact factor: 5.952

6.  Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.

Authors:  Jong-Chan Youn; Yoo Jin Hong; Hye-Jeong Lee; Kyunghwa Han; Chi Young Shim; Geu-Ru Hong; Young Joo Suh; Jin Hur; Young Jin Kim; Byoung Wook Choi; Seok-Min Kang
Journal:  Eur Radiol       Date:  2017-04-24       Impact factor: 5.315

7.  Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling.

Authors:  Shuli Wang; Hongjie Hu; Minjie Lu; Arlene Sirajuddin; Jinghui Li; Jing An; Xiuyu Chen; Gang Yin; Tian Lan; Linlin Dai; Yan Zhang; Xiaorong Yin; Lei Song; Aimin Dang; Peter Kellman; Andrew E Arai; Shihua Zhao
Journal:  Eur Radiol       Date:  2017-04-24       Impact factor: 5.315

Review 8.  Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.

Authors:  Jerry D Estep; Arvind Bhimaraj; A M Cordero-Reyes; Brian Bruckner; Matthias Loebe; Guillermo Torre-Amione
Journal:  Methodist Debakey Cardiovasc J       Date:  2012 Jul-Sep

9.  Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy.

Authors:  Tomas G Neilan; Otavio R Coelho-Filho; Ravi V Shah; Jiazuo H Feng; Diego Pena-Herrera; Damien Mandry; Francois Pierre-Mongeon; Bobak Heydari; Sanjeev A Francis; Javid Moslehi; Raymond Y Kwong; Michael Jerosch-Herold
Journal:  Am J Cardiol       Date:  2012-12-08       Impact factor: 2.778

Review 10.  Myocardial T1 and ECV Measurement: Underlying Concepts and Technical Considerations.

Authors:  Austin A Robinson; Kelvin Chow; Michael Salerno
Journal:  JACC Cardiovasc Imaging       Date:  2019-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.